ReviewMedical oncology (Northwood, London, England)2026

Beyond KRASG12C: emerging therapeutic strategies, patent landscape, and clinical progress in targeting KRAS-mutant cancers.

Srijita Chatterjee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.